Stockscreener 앱 받기
3.72
3.91%
0.14
시간 외 거래:
3.64
-0.08
-2.15%
전일 마감가:
$3.58
열려 있는:
$3.58
하루 거래량:
2.48M
Relative Volume:
1.94
시가총액:
$642.95M
수익:
-
순이익/손실:
$-54.70M
주가수익비율:
-11.27
EPS:
-0.33
순현금흐름:
$-51.36M
1주 성능:
+13.41%
1개월 성능:
+37.78%
6개월 성능:
+43.08%
1년 성능:
-18.06%
1일 변동 폭
$3.58
$3.83
1주일 범위
$3.21
$3.83
52주 변동 폭
$1.89
$4.70
사바라 Stock (SVRA) Company Profile
명칭
Savara Inc
전화
51285113796
주소
6836 BEE CAVE ROAD, AUSTIN, TX
SVRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SVRA
Savara Inc
|
3.72 | 618.76M | 0 | -54.70M | -51.36M | -0.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
사바라 Stock (SVRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-15 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-05-29 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-12-20 | 개시 | Wells Fargo | Overweight |
| 2024-11-13 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2024-02-15 | 개시 | JMP Securities | Mkt Outperform |
| 2023-11-07 | 개시 | Guggenheim | Buy |
| 2023-05-16 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-03-31 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-03-16 | 개시 | Piper Sandler | Overweight |
| 2021-03-15 | 개시 | Oppenheimer | Outperform |
| 2019-06-13 | 재확인 | H.C. Wainwright | Buy |
| 2019-06-13 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-06-13 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2018-08-13 | 재개 | ROTH Capital | Neutral |
| 2018-01-03 | 개시 | Ladenburg Thalmann | Buy |
| 2017-09-27 | 재개 | ROTH Capital | Buy |
| 2017-09-22 | 개시 | Jefferies | Buy |
| 2017-09-11 | 개시 | JMP Securities | Mkt Outperform |
모두보기
사바라 주식(SVRA)의 최신 뉴스
Trend analysis for Savara Inc. this weekInsider Selling & Reliable Breakout Forecasts - Newser
Savara Showcases Promising Phase 3 Trial Data for Molgramostim at ATS 2025 - MSN
What are the risks of holding Savara Inc.July 2025 News Drivers & AI Enhanced Trade Execution Alerts - خودرو بانک
Regression analysis insights on Savara Inc. performanceJuly 2025 Breakouts & Weekly Setup with High ROI Potential - Newser
Can Savara Inc. grow without external fundingWeekly Market Outlook & AI Forecasted Entry/Exit Points - خودرو بانک
Is Savara Inc. subject to activist investor interestMarket Movers & Real-Time Stock Entry Alerts - خودرو بانک
Will Savara Inc. stock go up soonMarket Volume Report & Expert Curated Trade Setups - Newser
What high frequency data says about Savara Inc.Weekly Trend Summary & Consistent Growth Equity Picks - Newser
Savara Inc. to Present at Upcoming Healthcare Investor Conferences - MSN
H.C. Wainwright raises Savara stock price target to $8 on larger patient pool By Investing.com - Investing.com South Africa
Savara Inc. stock chart pattern explainedIPO Watch & Reliable Entry Point Alerts - Newser
Published on: 2025-09-05 01:53:57 - Newser
H.C. Wainwright raises Savara stock price target to $8 on larger patient pool - Investing.com Canada
Price action breakdown for Savara Inc.July 2025 Decliners & Daily Stock Trend Reports - Newser
What candlestick patterns are forming on Savara Inc.2025 Key Lessons & Weekly Top Gainers Alerts - Newser
Is Savara Inc. stock a value trapWeekly Market Outlook & Weekly High Return Opportunities - خودرو بانک
What’s the recovery path for long term holders of Savara Inc.Treasury Yields & Low Drawdown Trading Techniques - Newser
What machine learning models say about Savara Inc.Trade Analysis Report & Momentum Based Trading Ideas - Newser
Savara (SVRA) Surges 3.32% on Analyst Upgrade and Positive Phase 3 Trial Data - AInvest
Movement Recap: Is Savara Inc. stock a good dividend stockWeekly Risk Summary & Fast Entry and Exit Trade Plans - khodrobank.com
Sector ETF performance correlation with Savara Inc.Weekly Gains Report & Community Trade Idea Sharing - Newser
Will Savara Inc. continue its uptrendWeekly Investment Recap & Smart Investment Allocation Tips - Newser
Savara’s Expanding aPAP Market and Strategic Moves Justify Buy Rating with Increased Price Target - TipRanks
Leading vs lagging indicators on Savara Inc. performanceTake Profit & Growth Focused Stock Pick Reports - Newser
Market reaction to Savara Inc.’s recent newsQuarterly Trade Summary & Daily Price Action Insights - Newser
Comparing Savara Inc. in custom built stock radarsJuly 2025 Movers & Safe Capital Growth Tips - Newser
Is Savara Inc. stock poised for growth2025 EndofYear Setup & Technical Confirmation Alerts - Newser
How institutional ownership impacts Savara Inc. stockEarnings Growth Report & Free Expert Verified Stock Movement Alerts - Newser
Savara Highlights MOLBREEVI Development in New Presentation - TipRanks
Will a bounce in Savara Inc. offer an exitJuly 2025 Breakouts & Real-Time Market Trend Scan - Newser
Savara Announces New U.S. Health Claims Data Analysis Finds Over 50% Increase in the Estimated Numbe - PharmiWeb.com
Does Savara Inc. stock reflect fundamentals2025 Market WrapUp & Weekly Top Gainers Trade List - خودرو بانک
50% Jump in Rare Lung Disease Patients: Savara Finds 5,500 U.S. Cases Ahead of FDA Drug Review - Stock Titan
Can Savara Inc. reach all time highs this yearMarket Growth Summary & Weekly Return Optimization Plans - خودرو بانک
Savara’s SWOT analysis: molbreevi’s potential reshapes rare respiratory stock outlook - Investing.com
Earnings Chart Overlay Points to Savara Inc. Upside getLinesFromResByArray error: size == 0 - 강소기업뉴스
Will Savara Inc. announce a stock split2025 Technical Overview & Precise Swing Trade Alerts - خودرو بانک
Quant Funds Rotate Into Savara Inc. StockJuly 2025 Summary & Verified High Yield Trade Plans - beatles.ru
Earnings visualization tools for Savara Inc.Weekly Profit Report & Daily Volume Surge Trade Alerts - Newser
Published on: 2025-08-31 18:39:16 - Newser
사바라 (SVRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):